FDA Investigator Humberto Z Gomez

Humberto Z Gomez has inspections in 7 countries as of 08 Dec 2023. Humberto Z Gomez has collaborated with a combinined 1850 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
103
Last Inspection Date:
08 Dec 2023
Investigator Role:
FDA Investigator
Redica ID:
100008462
Country:
United States of America, Poland, China, Australia, Mexico, Canada, Vietnam
Co-Investigator(s):
A Williams, Alanna Lmussawwir Bias, Alex G Kalugin, Amanda E Lewin, PhD, Andersoneric, Angel K Sandhu, Angela Shepas, Anna L Marroquin, Anna L Viveros Hernandez, Anthony E Keller, RPh, Ashar P Parikh, Capri R Woolridge, Carr, CDR Rochelle B Young, RPh, MSA, Charles A Snipes, PhD, Christine M Parmentier, Christopher J Lee, Cynthia Jim, CSO, Cynthia L Evitt, Da Lin Yao, MD, PhD, Darlene B Almogela, Deborah K Richardson, Dena L Jacobs, Diane Cvan Leeuwen, Dr. Zhou Chen (nmi), MD PhD, Dustin P Tran, Dustin R Abaonza, Edward D Haris, Edward D Harris, Edward D Vains, Erica L Nicoll, Estefania Fernandez, Gene D Arcy, Greg K Keshishyan, Gulshan R Anand, Helen J Hamaoka, Himanshu Gupta, PhD, Ingrid A Zambrana, Ismael Garibay, James A Lane, James R Fleckenstein, Jane M Kreis, Jazmine M Welcher, Jeffrey W Shrifter, DPM, Joan Briones, Joan T Briones, Joanne M Fukuda, Jocelyn E Massey, Jonathan M Mcbride, Jorge L Bertran, Joseph M Willems, Julian C Hanson, Juliane Kjung Lau, Kara A Scheibner, PhD, Karen J Bak, Karen M Willis, Kelvin Cheung, Lance M De Souza, MBA, Laurissa S Flowers, LCDR Jennifer H Rhyu, Leongc, Ligia M Sanders, Linda Linh T Nguyen, Linh Tu, Lirissia Mccoy, Lisa H Nakagawa, Lori J Silverstein, Lucila B Nwatu, Lydia S Chan, Macropolk, Marcus F Yambot, Marie K Kinkade, Mark C Saale, Mark E Baldwin, Mark E Chan, Mary Ewilkerson Brinsko, Mary R Hole, Melkamu Getie Kebtie, PhD, Ni A Khin, MD, Peter E Baker, Rebecca T Davis, Robert S Sweeton, Ronald L Koller, Sandra S Saniga, Sara Jdent Acosta, Sarah A Hassas, Scott N Lim, Sergio Chavez (NMI), Shelley H Beausoleil, Sherri N Rohlf, MD, State Agency, Steven M Galvez, Stuart Kim, Stuart W Russel, Stuart W Russell, Suzanne M Healy, Tawny L Colling, Thea C Grome, Thomas Cote, Thomas W Gordon, Timothy C Grome, Timothy P Lafave, Tomanik'e C Banks, Xiaohan Cai, PhD, Yangmin Ning

Humberto Z Gomez's Documents

Publish Date Document Type Title
August, 2021 FDA 483 Mehrnaz Hojjati MD - Form 483, 2021-08-26
July, 2020 EIR Andrew D. Leavitt MD - EIR, 2020-07-02
June, 2017 FDA 483 Samer Nakhle, M.D. - Form 483, 2017-06-30
October, 2021 FDA 483 Jose Luis Bautista, M.D. - Form 483, 2021-10-06
June, 2019 FDA 483 UCLA Medical IRB 1 (OHRPP) - Form 483, 2019-06-26
February, 2023 FDA 483 Dante Pieramici, M.D. - Form 483, 2023-02-10
August, 2021 EIR Mehrnaz Hojjati MD - EIR, 2021-08-26

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more